This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Herbert Schmid: Innovator in Pharmaceutical Science
Introduction
Herbert Schmid, a distinguished inventor based in Neuenburg, Germany, is renowned for his significant contributions to the field of pharmaceutical science. With a total of six patents to his name, he has made remarkable strides in developing innovative therapeutic solutions that address critical health issues.
Latest Patents
Among his latest patents, Schmid has developed novel methods concerning the use of somatostatin analogs in managing hypoglycemia. This invention highlights a somatostatin (SRIF) analog that exhibits high binding affinity to human receptors SSTR1, 2, 3, and 5. It proposes the preparation of a pharmaceutical composition specifically designed for hypoglycemia control.
In another groundbreaking patent, Schmid explores the combination of somatostatin analogs with 11beta-hydroxylase inhibitors. This combination aims to create a medicament that treats diseases associated with elevated stress hormone levels. His patents not only contribute to medical science but also pave the way for novel therapeutic interventions.
Career Highlights
Schmid currently works at Novartis AG, a leading global healthcare company known for its innovative medicines and commitment to improving patient outcomes. His role at Novartis allows him to engage in cutting-edge research and development, furthering his ability to make a meaningful impact within the pharmaceutical industry.
Collaborations
Throughout his career, Schmid has collaborated with esteemed colleagues, including Germo Hans Gericke and Mario Roberto Maldonado Lutomirsky. These partnerships have fostered a supportive environment for innovative thinking and have led to the development of impactful medical solutions that benefit patients globally.
Conclusion
Herbert Schmid exemplifies the spirit of innovation in the pharmaceutical industry. His inventiveness, along with his collaboration with talented individuals, highlights the importance of teamwork in achieving scientific breakthroughs. As he continues to develop patented methods and compositions, Schmid remains a vital contributor to advancing healthcare solutions for the well-being of patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile